These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37879354)

  • 21. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
    Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP
    BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmopressin 30 years in clinical use: a safety review.
    Vande Walle J; Stockner M; Raes A; Nørgaard JP
    Curr Drug Saf; 2007 Sep; 2(3):232-8. PubMed ID: 18690973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
    Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
    Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
    J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Hyponatremia After Desmopressin Diacetate Arginine Vasopressin Infusion in an Older Woman.
    Yalcin A; Silay K; Yilmaz T; Atmis V; Atli T
    J Am Geriatr Soc; 2016 May; 64(5):1138-9. PubMed ID: 27225368
    [No Abstract]   [Full Text] [Related]  

  • 26. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.
    Juul KV; Bichet DG; Nørgaard JP
    Endocrine; 2011 Aug; 40(1):67-74. PubMed ID: 21626284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyponatremic encephalopathy caused by desmopressin-induced hyponatremia.
    Ragoschke-Schumm A; Witte OW; Terborg C
    J Neurol; 2005 Nov; 252(11):1411-3. PubMed ID: 15864684
    [No Abstract]   [Full Text] [Related]  

  • 28. Desmopressin and the risk of hyponatremia: A population-based cohort study.
    Fralick M; Schneeweiss S; Wallis CJD; Jung EH; Kesselheim AS
    PLoS Med; 2019 Oct; 16(10):e1002930. PubMed ID: 31634354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
    Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
    Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmopressin acetate nasal spray for adults with nocturia.
    Cohn JA; Kowalik CG; Reynolds WS; Kaufman MR; Milam DF; Dmochowski RR; Wein AJ
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1281-1293. PubMed ID: 29048257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of desmopressin for the treatment of nocturia in elderly patients: a cohort study.
    Song M; Hong BS; Chun JY; Han JY; Choo MS
    Int Urol Nephrol; 2014 Aug; 46(8):1495-9. PubMed ID: 24595604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.
    Chin X; Teo SW; Lim ST; Ng YH; Han HC; Yap F
    Eur J Clin Pharmacol; 2022 Jun; 78(6):907-917. PubMed ID: 35199198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Desmopressin therapy of nocturia in elderly patients may contribute to severe hyponatraemia].
    Sivalingam S; Sonne MP; Eldrup E
    Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
    Atila C; Loughrey PB; Garrahy A; Winzeler B; Refardt J; Gildroy P; Hamza M; Pal A; Verbalis JG; Thompson CJ; Hemkens LG; Hunter SJ; Sherlock M; Levy MJ; Karavitaki N; Newell-Price J; Wass JAH; Christ-Crain M
    Lancet Diabetes Endocrinol; 2022 Oct; 10(10):700-709. PubMed ID: 36007536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent hyponatremia under desmopressin overdosing: is abuse a possible explication?
    Hillemacher T; Schanze A; Kraus T; Kornhuber J; Bleich S
    Am J Emerg Med; 2007 Feb; 25(2):239-40. PubMed ID: 17276835
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyponatraemia associated with lamotrigine in cranial diabetes insipidus.
    Mewasingh L; Aylett S; Kirkham F; Stanhope R
    Lancet; 2000 Aug; 356(9230):656. PubMed ID: 10968444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review: Treatment of neurohypophyseal diabetes insipidus.
    Oiso Y; Robertson GL; Nørgaard JP; Juul KV
    J Clin Endocrinol Metab; 2013 Oct; 98(10):3958-67. PubMed ID: 23884783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meloxicam-desmopressin drug-drug interaction producing hyponatremia.
    Bojdani E; Chen A; Buonocore S; Li KJ; Gurrera R
    Psychiatry Res; 2019 Sep; 279():284-286. PubMed ID: 31084937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reset Osmostat: The Result of Chronic Desmopressin Abuse?
    Andreoli DC; Whittier WL
    Am J Kidney Dis; 2017 Jun; 69(6):853-857. PubMed ID: 28223002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delay in desmopressin therapy: Disaster in waiting.
    Kroll C; Zandvakili A
    J Clin Pharm Ther; 2022 Dec; 47(12):2376-2378. PubMed ID: 36376238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.